🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Belinda Lee

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-0947-9834

Also affiliated with The University of Melbourne, Northern Health, Walter and Eliza Hall Institute of Medical Research, Peter MacCallum Cancer Centre

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies”.

Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies

International Journal of Cancer(2020)10.1002/ijc.33312
N/A
4.7DataRank · unranked
113 citations

Joshua D. Cohen, Serigne Lo, Yuxuan Wang, Lu Li, Michael Christie +23 more

Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆

Annals of Oncology(2020)10.1016/j.annonc.2020.04.471
N/A
3.5DataRank · unranked
110 citations

Alexander N. Shoushtari, D Chauhan, David Palmieri, Belinda Lee, Maartje W. Rohaan +20 more

Clinical Implementation and Initial Experience With a 1.5 Tesla MR-Linac for MR-Guided Radiation Therapy for Gynecologic Cancer: An R-IDEAL Stage 1 and 2a First in Humans Feasibility Study of New Technology Implementation

Practical Radiation Oncology(2022)10.1016/j.prro.2022.03.002
N/A
0.660DataRank · unranked
11 citations

Jinzhong Yang, Sastry Vedam, Jihong Wang, Belinda Lee, Angela Sobremonte +9 more

ctDNA-guided adjuvant chemotherapy escalation in stage III colon cancer: Primary analysis of the ctDNA-positive cohort from the randomized AGITG dynamic-III trial (intergroup study of AGITG and CCTG).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.3503
N/A
0.470DataRank · unranked
22 citations

Yuxuan Wang, Jonathan M. Loree, Joshua D. Cohen, David Espinosa Espinosa, Rachel Wong +15 more

Clinical implementation and initial experience with a 1.5 Tesla MR-linac for MR-guided radiotherapy for gynecologic cancer: An R-IDEAL stage 1/2a first in humans/feasibility study of new technology implementation

medRxiv(2021)10.1101/2021.12.03.21266962
N/A
0DataRank · unranked
1 citations

Jinzhong Yang, Sastry Vedam, Jihong Wang, Belinda Lee, Angela Sobremonte +9 more

Use of Specific Duodenal Dose Constraints During Treatment Planning Reduces Toxicity After Definitive Paraaortic Radiation Therapy for Cervical Cancer

Practical Radiation Oncology(2021)10.1016/j.prro.2021.12.008
N/A
0DataRank · unranked
5 citations

Juliana Wu, Bhavana V. Chapman, Zhiqian Yu, Belinda Lee, Ann H. Klopp +4 more

Case report: Cardiac neuroendocrine carcinoma and squamous cell carcinoma treated with MR-guided adaptive stereotactic radiation therapy

Frontiers in Oncology(2024)10.3389/fonc.2024.1411474
N/A
0DataRank · unranked
2 citations

Julius Weng, Angela Sobremonte, Belinda Lee, Neil Hughes, Mustefa Mohammedsaid +10 more

Online adaptive planning for prostate stereotactic body radiotherapy using a 1.5 Tesla magnetic resonance imaging-guided linear accelerator

Physics and Imaging in Radiation Oncology(2020)10.1016/j.phro.2020.12.001
N/A
0DataRank · unranked
20 citations

Sastry Vedam, Belinda Lee, Pamela Castillo, Angela Sobremonte, Neil Hughes +4 more